Eiger BioPharmaceuticals EIGR

$ 1.73 -9.21%

Annual report 2023
added 04-08-2024

Eiger BioPharmaceuticals Long Term Debt 2011-2024 | EIGR

Annual Long Term Debt Eiger BioPharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	39.6 M	31.8 M	31.2 M	30.4 M	25.6 M	13.1 M	14.7 M	-	10.1 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
39.6 M	10.1 M	24.6 M

Quarterly Long Term Debt Eiger BioPharmaceuticals

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
40.7 M	40.3 M	40 M	39.6 M	39.3 M	-	19.4 M	24 M	28.5 M	31.4 M	31.2 M	31.2 M	31.2 M	31.2 M	31.2 M	30.4 M	30.4 M	30.4 M	30.4 M	25.6 M	25.6 M	25.6 M	25.6 M	13.1 M	13.1 M	13.1 M	13.1 M	14.7 M	-	14.7 M	14.7 M	-	-	10 K	8.71 M	11.8 M	9.91 M	10.1 M	10.1 M	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
40.7 M	10 K	23.7 M